Ranbaxy should be squared off by end of day: Deepak Mohoni

"In the short sales, there is Ranbaxy, stock that has started floundering a little bit in this decline and it is day trade, should be squared off by the end of the day."

| Updated: Nov 16, 2011, 11.40 AM IST

In a chat with ET Now, Deepak Mohoni, Director, trendwatchindia.com, shares his views on Ranbaxy.

What is the call on Ranbaxy?

In the short sales, there is Ranbaxy, stock that has started floundering a little bit in this decline and it is day trade, should be squared off by the end of the day.

Not making enough money in stocks? Click here for real-life stories of successful investors.

Too busy to trade in stocks? Invest in Mutual Funds with ET Money!